Protagonist Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
9.11 | 57.09 | -84.05% | -6.22 | -246.44% |
| P/S |
|
5.77 | 33.5 | -82.78% |
|
|
| P/BV |
|
3.71 | 4.61 | -19.57% |
|
|
| P/FCF |
|
6.13 | 39.66 | -84.55% |
|
|
| Ev/Ebitda |
|
9.57 | -19.46 | -149.19% |
|
|
| Ev/S |
|
5.57 | 22.56 | -75.31% |
|
|
| Ev/FCF |
|
13.24 | 45.47 | -70.89% |
|
|
| E/P |
|
0.2457 | 0.0172 | 1324.57% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
58.2 | -14.42 | -503.59% | -194.93 | -129.86% |
| ROE |
|
54.39 | 9.01 | 503.6% |
|
|
| ROA |
|
49.91 | 0.0151 | 329471.64% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
63.34 | -26.5 | -338.99% |
|
|
| ROCE |
|
-13.87 | 13.75 | -200.85% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.043 | -3.73 | -101.15% | -0.00038 | -11 412.67% |
| Nеt Debt/Ebitda |
|
-0.3416 | -3.19 | -89.3% |
|
|
| Debt/Ratio |
|
0.0146 | 0.1777 | -91.79% |
|
|
| Debt/Equity |
|
0.0161 | 1.57 | -98.98% |
|
|
| Debt/Net Income |
|
0.0395 | 0.8429 | -95.32% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5467 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4967 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.73 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5467 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
1417.51 | 73.67 | 1824.13% | ||
| Growth impulse Ebitda in 5 years |
|
-497.16 | 15.28 | -3353.66% | ||
| Growth impulse Net Income in 5 years |
|
-516.01 | -33.08 | 1459.89% | ||
| Growth impulse FCF in 5 years |
|
-350.56 | -6.99 | 4915.16% | ||
| Growth impulse EPS in 5 years |
|
-319.88 | -59.11 | 441.16% |
IP Score
5.26/10
